Promising Novel SIRT1 Activators For Treating Diseases Of Aging Unveiled By Sirtris
"Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes"
Sirtris Pharmaceuticals, Inc. , a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging, has announced that findings in the journal Nature demonstrate ... via MediLexicon